IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 310 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.97 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $271,000 | +44.9% | 5,248 | +17.1% | 0.00% | 0.0% |
| Q2 2018 | $187,000 | -5.6% | 4,483 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $198,000 | -15.0% | 4,483 | -3.3% | 0.00% | 0.0% |
| Q4 2017 | $233,000 | -13.1% | 4,634 | -12.3% | 0.00% | -25.0% |
| Q3 2017 | $268,000 | -5.0% | 5,285 | -4.5% | 0.00% | 0.0% |
| Q2 2017 | $282,000 | +17.0% | 5,535 | -7.8% | 0.00% | 0.0% |
| Q1 2017 | $241,000 | -16.0% | 6,002 | +0.0% | 0.00% | -33.3% |
| Q4 2016 | $287,000 | -78.9% | 6,000 | -83.8% | 0.01% | -75.0% |
| Q3 2016 | $1,359,000 | +66.7% | 37,100 | +6.0% | 0.02% | +50.0% |
| Q2 2016 | $815,000 | -63.1% | 35,000 | -35.8% | 0.02% | -62.8% |
| Q1 2016 | $2,207,000 | -53.1% | 54,500 | -28.3% | 0.04% | -47.6% |
| Q4 2015 | $4,710,000 | – | 76,060 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |